TVRD - Tvardi Therapeutics, Inc.
Tvardi Therapeutics, Inc. Logo

TVRD - Tvardi Therapeutics, Inc.

https://tvarditherapeutics.com
Buy Momentum: Bearish
Recent News
Powered by Alpha Vantage
Bullish
Recently Listed Tvardi Therapeutics' Lead Drug 'Positioned To Drive Broad Improvement', Analyst Sees Over 150% Stock Upside - Tvardi Therapeutics ( NASDAQ:TVRD )
Benzinga • 3 months ago • score: 0.32
Piper Sandler sets $78 target on Tvardi, seeing 150%+ upside based on TTI-101's potential. Tvardi has cash runway into H2 2026, covering two Phase 2 readouts in IPF and HCC. 9 Out of the Last 10 Summers this "Power Pattern" Delivered Winners - Get The Details Now. Newly public Tvardi ...
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-09 (Snapshot)

None

52W High
$34.31
52W Low
$8.14
MA Status:
50D: Above 200D: Above
Beta (~1 neutral, <0.9 lower risk)
N/A
Valuation
As of 2025-03-31 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
N/A
EV/Revenue (<3 favorable)
N/A
P/S (TTM) (<3 favorable)
N/A
P/B (<3 favorable)
N/A
Ownership
Retail‑heavy
Source: Overview
Insiders (1–5% typical)
27.53%
Institutions (25–75% balanced)
2.76%
Shares Outstanding
9,360,900
Float
0
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
As of 2025-03-31 (Overview)
Revenue (TTM)
0
Gross Profit (TTM)
0
EPS (TTM)
-2.25
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
N/A
ROE (TTM) (>15% strong)
N/A
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
N/A
Momentum
Bearish momentum
Value
1.6172
Previous
1.5356
Trend
Rising
Signal Cross
No cross
As of
Sep. 04, 2025